Abstract
Electrodermal activity (EDA) is a measure of sympathetic arousal that has been linked to depression in laboratory experiments. However, the inability to measure EDA passively over time and in the real-world has limited conclusions that can be drawn about EDA as an indicator of mental health status outside of controlled settings. Recent smartwatches have begun to incorporate wrist-worn continuous EDA sensors that enable longitudinal measurement of sympathetic arousal in every-day life. This work (N=237, 4-week observation period) examines the association between passively collected, diurnal variations in EDA and symptoms of depression, anxiety and perceived stress in a large community sample. Subjects who exhibited elevated depressive and anxiety symptoms had higher tonic EDA, skin temperature, and heart rate, despite not engaging in greater physical activity, compared to those that were not depressed or anxious. In contrast, subjects who exhibited elevated stress only exhibited higher skin temperature. Most strikingly, differences in EDA between those with high versus low symptoms were most prominent during the early morning. We did not observe amplitude or phase differences in the diurnal patterns. Our work suggests that electrodermal sensors may be practical and useful in measuring the physiological correlates of mental health symptoms in free-living contexts and that recent consumer smartwatches might be a tool for doing so.
Competing Interest Statement
Daniel McDuff, Isaac Galatzer-Levy, Seamus Thomson, Andrew Barakat, Conor Heneghan, Samy Abdel-Ghaffar, Jake Sunshine, Ming Zher-Poh, Lindsey Sunden, John Hernandez, Allen Jiang, Xin Liu, Benjamin W. Nelson were employed by Alphabet and received stock as part of the normal compensation.
Funding Statement
This study was funded by Google.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by The Committee for Protection of Human Subjects (CPHS), the University of Oregon Institutional Review Board (IRB). It was defined as a Social Science/Behavioral research study. Study Title: VICO: Android Digital Wellbeing Study. Study ID: MOD00000379
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
We support open science principles, but also recognize that it is often challenging to ensure participant privacy while also making data broadly available to the academic research community. We had to balance these considerations with the privacy of the participants and protection of their health data. Furthermore, although the data could be de-identified, some of the data streams could not be fully anonymized. We recognize that this is a limitation, but we felt that we needed to give the participants strong reassurance that their data would not be used for any other purpose than for the research at hand.
